ArticleScientific reports2023

Novel VEGFR2 inhibitors with thiazoloquinoxaline scaffold targeting hepatocellular carcinoma with lower cardiotoxic impact.

Reham M M El-Hazek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.